PROBODY

Biochemicals, namely, proteolytically-activatable or protease-activatable, or proteolytically activated or protease-activated immunoglobulin and antigen-binding fragments for binding to tissue; diagnostic and therapeutic kits consisting of proteolytically-activatable or protease-activatable, or proteolytically-activated or protease-activated immunoglobulin and antigen-binding fragments for binding to tissue; immunoglobulin for drug conjugation and targeted cell binding for laboratory and research use

Engineered cell therapies for medical purposes, namely, for use in treating cancer

Scientific research and development in the field of therapeutic biochemicals, engineered cell therapies and immunotherapy; medical and scientific research and development for agents, preparations, products and technology in the field of dysregulated proteolytic activities; providing medical and scientific research information in the fields of biochemicals, engineered cell therapies, immunotherapy, oncology and dysregulated proteolytic activity; scientific investigations for medical purposes; medical research